ABSTRACT
The working heart is a highly metabolically active organ that consumes close to 10% of the total body oxygen consumption. It extracts nearly 70% of the oxygen supplied by the coronary circuit but has little capability for extracting additional oxygen. Accordingly, increased metabolic demands are met through coronary vasodilation resulting in increased blood flow and oxygen delivery. (1,2) As a result, a severe energy imbalance develops during cardiac arrest shortly after coronary blood flow ceases. The severity of the energy deficit is contingent on the metabolic requirements and is particularly high when ventricular fibrillation (VF) is present; because the energy needs of the fibrillating heart are the same or more than the normally beating heart. (3) A lesser energy requirement occurs when cardiac arrest occurs in the quiescent or minimally active heart (i.e., asystole or pulseless electrical activity as a result of asphyxia or exsanguinations). (4) However, most experimental studies have examined the myocardial manifestations of cardiac arrest and resuscitation in animal models of VF. After cessation of coronary blood flow and oxygen delivery, the mitochondrial capability for ATP regenerating through oxidative phosphorylation stops prompting anaerobic regeneration of limited amount of ATP at the substrate level from breakdown of creatine phosphate and oxidation of pyruvate to lactate. (5) (6) (7) This leads to rapid depletion of creatine phosphate, marked elevation in lactate, and a relatively slow depletion of ATP. (6) We observed in a rat model of VF, that 10 minutes of untreated VF were accompanied by decreases in myocardial creatine phosphate and ATP to levels corresponding to 7% and 19% of baseline, respectively, whereas the lactate content increased by more than 50-fold. (8) Along with the energy deficit, ischemia is accompanied by accumulation of CO 2 and H + yielding profound myocardial acidosis. (9) Acidosis, however, is believed to be protective. Several studies have shown that hypoxic cells and tissues are preserved better in an acidic environment. (10) (11) (12) Conventional closed-chest resuscitation is hemodynamically limited failing to generate a coronary blood flow greater than 20% of normal. (13) Such low flow fails to reverse myocardial ischemia but is sufficient to activate multiple pathogenic mechanisms triggering what is known as reperfusion injury. Accordingly, resuscitation typically proceeds during and in spite of severe myocardial ischemia and in the midst of reperfusion injury compounded by specific resuscitation interventions which can also injure the myocardium, such as electrical shocks and adrenergic vasopressor agents. The end result is that several functional myocardial abnormalities develop during cardiac resuscitation which may compromise resuscitability and survival. These myocardial abnormalities can be grouped into those that manifest during the resuscitation effort and those that manifest after return of spontaneous circulation. The former include decreased left ventricular compliance and increased resistance to electrical defibrillation; the latter include reperfusion arrhythmias and myocardial dysfunction.
Decreased left ventricular compliance
A progressive reduction in left ventricular compliance characterized by reductions in cavity size and wall thickening but without changes in cavity pressure has been documented by our group and others during closed-chest resuscitation. (14-17) A comparable phenomenon has been reported in humans during open-chest direct cardiac compression. (18) Decreases in left ventricular compliance can compromise preloaddependent blood flow generation and partly explain time-dependent reductions in the hemodynamic efficacy of closed-chest resuscitation. (16, 17) We have reported that this phenomenon can be prevented by administration of inhibitors of the sodium-hydrogen exchanger isoform-1 (NHE-1), enabling in closed-chest models to prolong the duration of hemodynamically effective chest compression. (16, 17) We have previously interpreted decreases in left ventricular compliance as a manifestation of ischemic contracture. (3, 16) However, ischemic contracture is characteristically preceded by reductions in myocardial ATP to less than 10% of normal, (19) and typically occurring after long intervals of no-flow ischemia. In recent studies we have reported decreases in ventricular compliance with myocardial ATP levels of ≈ 55% of baseline and prevention by the NHE-1 inhibitor zoniporide. (20) This would suggest that reperfusion leading to Na + -induced cytosolic Ca 2+ overload may play a critical role. However, delayed reversal of intracellular acidosis by NHE-1 inhibition at the time of reperfusion may also contribute to preserve compliance. (21) Resistance to defibrillation Electrical shocks delivered immediately after onset of VF are consistently effective in terminating VF and reestablishing mechanical cardiac activity. Even short delays (i.e. up to 3 minutes) may not be substantially detrimental resulting in more than 50% likelihood of successful resuscitation. (22) However, longer intervals of untreated VF, as characteristically occurs in out-of-hospital settings, are associated with decreased effectiveness of defibrillation attempts. Under these conditions electrical shocks typically fail to terminate VF, or terminate VF precipitating asystole or a pulseless electrical activity. (23) Additional resuscitation interventions are required to restore myocardial conditions favorable to successful defibrillation. New approaches are being developed to optimize the effectiveness of electrical defibrillation by identifying the proper timing for shock delivery and by using safer and more effective defibrillation waveforms. (24, 25) 
Reperfusion arrhythmias
Electrical instability manifested by premature ventricular complexes and episodes of ventricular tachycardia and VF commonly occurs during the early minutes after return of cardiac activity. Episodes of VF have been reported to occur in up to 79% of patients, with the number of episodes inversely correlated with ultimate survival. (26) The mechanisms responsible for postresuscitation arrhythmias are complex but probably involve prominently cytosolic Ca 2+ overload with afterdepolarizations triggering ventricular ectopic activity. (27) In addition, there are repolarization abnormalities that include shortening of the action potential (AP) duration, decreased AP amplitude, and development of AP duration alternant creating conditions for reentry. (28) Experimentally, these repolarization abnormalities are short-lived (5 to 10 minutes) and coincide with the interval of increased propensity for ventricular arrhythmias and recurrent VF. (16) We have reported marked attenuation of reperfusion arrhythmias and prevention of episodes of refibrillation by NHE-1 inhibitors given during cardiac resuscitation in various animal models. (14, 16, 29) Postresuscitation myocardial dysfunction
Variable degrees of left ventricular systolic and diastolic dysfunction develop after resuscitation from cardiac arrest despite full restoration of coronary blood flow. Left ventricular dysfunction is largely reversible, consistent with the definition of myocardial stunning. (30) (31) (32) (33) Systolic dysfunction has been documented using load-independent indices of contractility showing decreases in the slope of the end-systolic pressure-volume relationship, known as elastance, and increases in the volume intercept at a left ventricular pressure of 100 mm Hg (V 100 ). (31) Impaired contractility leads to reductions on global indices of ventricular performance such as cardiac index, ejection fraction, and left ventricular stroke work (32, 34, 35) and renders the heart susceptible to afterload increases during the postresuscitation phase. In a pig model of VF and closed chest resuscitation, the administration of vasopressin during cardiac resuscitation was associated with decreased left ventricular performance with reversal by administration of a specific antagonist of the V 1 receptor. (36) Diastolic dysfunction is characterized by left ventricular wall thickening with reductions in end-diastolic volume and impaired relaxation, (16) and appears to be maximal immediately after restoration of spontaneous circulation. The magnitude of diastolic dysfunction correlates closely with the magnitude of ischemic contracture, (37) suggesting a common pathogenic thread with diastolic dysfunction being a manifestation of resolving ischemic contracture. From a functional perspective, diastolic dysfunction may limit the compensatory ventricular dilatation required to overcome decreased contractility according to the Frank-Starling mechanism.
Effects of cardiac arrest and resuscitation on cardiac mitochondria
The underlying mechanism of cell injury during ischemia and reperfusion is complex and time-sensitive. Some processes develop coincident with the onset of ischemia and during reperfusion leading to abnormalities in energy metabolism, acid base status, and intracellular ion homeostasis. Other processes develop later and encompass activation of various signaling pathways that have deleterious or beneficial effects on specific effectors, but associated with sustained disruption of energy production, contractile dysfunction, and activation of apoptotic pathways. Discussion on the various cell mechanisms responsible for cell injury is beyond the scope of this review. However, pertinent to our discussion is the mounting evidence pointing to mitochondria as key target organelles of reperfusion injury. (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) 
Energy production
The mitochondria are organelles present in all eukaryotic cells and responsible for production of more than 90% of the ATP requirements. Mitochondria have an inner membrane that is highly impermeable and folds inwardly into the mitochondrial matrix forming multiple cristae where proteins responsible for oxidative phosphorylation reside. The outer mitochondrial membrane is more permeable given the abundance of channel-forming proteins, such as the voltage dependent anion channel (VDAC). Generation of ATP results from oxidation of NADH in the electron transport chain. This chain is composed of protein complexes assembled along the inner mitochondrial membrane where electrons are transferred down their redox potential while H + are pumped into the intermembrane space. The accumulation of H + in the intermembrane space establishes along with its voltage gradient (negative in the matrix side) a protonmotive force which is used by F o F 1 ATP synthase to form ATP from ADP and inorganic phosphate. Mitochondrial ATP is used to phosphorylates creatine, forming creatine phosphate which is then shuttled outside mitochondria to key sites where ATP is utilized to support contractile activity (acto-myosin ATPase), Ca 2+ reuptake (sarcoplasmic reticulum Ca 2+ ATPase), and resting membrane potential (sarcolemmal Na + -K + ATPase). (48, 49) Creatine phosphate rephosphorylates ADP, ensuring that adequate free energy for ATP hydrolysis is available at these reaction sites. (48) Dephosphorylated creatine is shuttled back to mitochondria for rephosphorylation closing the phosphotransfer circuit. (50, 51) Disruption of the inner membrane permeability leads to collapse of the H + gradient compromising the protonmotive force required for ATP synthesis. One important mechanism of disruption of the inner membrane permeability at the time of reperfusion is opening of the mitochondrial permeability transition pore (mPTP). The mPTP is a highconductance mega channel formed by apposition of transmembrane proteins from the inner and the outer mitochondrial membrane. (40) Opening of the pore − in addition to causing collapse of the inner membrane voltage and uncoupling oxidative phosphorylation − allows molecules up to 1.5 kDa to enter the mitochondrial matrix along with water and solutes. This leads to mitochondrial swelling with stretching and disruption of the outer mitochondrial membrane. (40) Factors present at the time of reperfusion and responsible for mPTP opening include Ca 2+ overload, production of reactive oxygen species, depletion of ATP and ADP, and increased inorganic phosphate. (40) Intracellular acidosis at the time of reperfusion appears to prevent mPTP opening.
Apoptotic signaling
In addition to the key role on energy production, mitochondria can also signal cell death by activation of the intrinsic apoptotic pathway through release of cytochrome c. Cytochrome c is a 14 kDa hemoprotein normally present in the intermembrane mitochondrial space that plays a key role transferring electrons from complex III to complex IV. However, cytochrome c can be released to the cytosol prompting the formation of an oligomeric complex with dATP and the apoptotic protease activating factor-1 (Apaf-1). (38) This complex recruits procaspase-9 forming the so-called apoptosome. In the apoptosome, procaspase-9 is activated and then released as caspase-9, which in turn, activates the executioner caspases 3, 6, and 7. (52,53) Active executioner caspases cleave several cytoplasmic proteins including α-spectrin and actin and nuclear proteins including poly (ADP-ribose) polymerase (PARP), lamin A, and the inhibitor of caspase activated DNase (ICAD). Cleavage of ICAD leads to activation of caspase activated DNase (CAD) which in turn cleaves chromatin into 180 to 200 bp fragments. Other substrates activated during apoptosis include components of DNA repair machinery and a number of protein kinases, (52) ultimately culminating in cell death. However, activation of apoptotic cascades does not necessarily end in cell death. We have recently reported activation of caspase-3 without evidence of DNA fragmentation. Other investigators have coined the term "apoptosis interruptus" (54) to indicate the same concept. In myocytes, apoptosis interruptus is associated with disruption of contractile proteins, (55) suggesting that it could represent and adaptive response to lower metabolic needs under conditions of metabolic stress. Several mechanisms may explain cytochrome c release. One involves mPTP opening causing matrix swelling and disruption of the outer mitochondrial membrane. However, cytochrome c can also be released without mPTP opening through formation of pores in the outer mitochondrial membrane. This mechanism is best explained by permeabilization of the outer membrane by pro-apoptotic proteins such as Bcl-2-associated X protein (Bax), Bcl-2 homologous antagonist killer (Bak), or truncated BH3 interacting domain death agonist (Bid). (56) Anti-apoptotic proteins such as Bcl-2, Bcl-x, and Bclw, however, may play important roles by counterbalancing the aforementioned pro-apoptotic effects. (57) We investigated in a rat model of ventricular fibrillation (VF) and closedchest resuscitation the effects of ischemia and reperfusion on cytosolic and systemic release of cytochrome c. (58) We found that cytochrome c is released to the cytosol after resuscitation from VF in association with activation of caspase-3 and marked reduction in left ventricular function. We then measured changes in plasma cytochrome c in 12 rats successfully resuscitated after 8 minutes of untreated VF and 8 minutes of closed-chest resuscitation. In 3 rats that survived, plasma cytochrome c increased and decreased gradually within a 96 hour interval to levels not exceeding 2 μg/ml. In 9 rats, which died between 1.3 and 32.5 hours post-resuscitation, plasma cytochrome c increased faster (0.7 ± 0.5 vs 0.1 ± 0.05 μg/ml/hr; p = 0.046) and reached higher levels (4.6 ± 2.0 vs 1.6 ± 0.3 μg/ml; p = 0.029) than in survivor rats. Plasma cytochrome c increased despite reversal of wholebody ischemia, which was documented by declining blood lactate levels in both survivor and non-survivor rats. Increased plasma levels of cytochrome c, inversely related to outcomes, have also been reported in patients presenting with the systemic inflammatory response syndrome, (59) influenzaassociated encephalopathy, (60) and fulminant hepatitis. (61) Accordingly, release of cytochrome c to the bloodstream may serve to identify mitochondrial injury, quantitate its severity, and predict survival. Future work is planned to assess the effects of interventions targeting mechanisms of mitochondrial injury during reperfusion, anticipating preservation of organ function and improved survival in relation to interventions that (i) ameliorate mitochondrial Ca 2+ overload and (ii) reduce the sensitivity of the mPTP. Amelioration of mitochondrial Ca 2+ overload can be accomplished by inhibition of the sodium-hydrogen exchanger isoform-1 using cariporide (16, 29) and by inhibition of the mitochondrial Ca 2+ uniporter using Ru360. (62) The sensitivity of mPTP can be reduced by use of cyclosporine A (63, 64) and the nonimmunosuppressive cyclosporine derivative NIM811. (65, 66) 
